DARIYA PAK: Open Payments
NPI 1972870095 · YORBA LINDA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$576 in 19 payments from 10 companies in 2025. Trend: 2023 $142 · 2024 $161 · 2025 $576
Food & beverage: $576
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 2 | $147 |
| Janssen Pharmaceuticals, Inc | 3 | $100 |
| Vanda Pharmaceuticals Inc. | 4 | $84 |
| Gilead Sciences, Inc. | 3 | $76 |
| Exact Sciences Corporation | 2 | $39 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $30 |
| Otsuka America Pharmaceutical, Inc. | 1 | $28 |
| Astellas Pharma US Inc | 1 | $26 |
| Hologic Sales and Service, LLC | 1 | $25 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
Products named: ARISTADA, INVEGA SUSTENNA, FANAPT, Cologuard Collection Kit, Kerendia, ABILIFY ASIMTUFII, Veozah, THINPREP 2000 PROCESSOR.
Industry payments across CA — which companies pay providers there.
